U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Senior Global Pricing Operations Partner

Finance & BankingUpdated on Nov 14
Full-timeAnderlecht, BelgiumNo salary listed

About the Job

Requirements

  • A bachelor's degree in life sciences, economics, finance, business, or data analytics is required.
  • At least five years of relevant experience in pricing, market access, health economics, or finance is required.
  • Strong pharmaceutical pricing expertise, including knowledge of governance and cross-market implications, is required.
  • Proven experience leading complex, high-impact, or cross-market pricing cases is required.
  • Strong analytical, project management, stakeholder management, and communication skills are required.
  • Excellent written and verbal English skills for global, cross-functional environments are required.

Responsibilities

  • Serve as the main global point of contact for operational pricing questions and processes for assigned affiliates.
  • Guide affiliates in developing business cases with the necessary analytics, ensure stakeholder alignment, and keep teams on track with decision-making timelines.
  • Assess the financial and cross-market implications and risks of pricing requests and escalate them when needed.
  • Develop in-market pricing policies for assigned brands.
  • Monitor price changes, ensure pricing decisions are documented and up to date in the system, and provide quarterly reports on price changes and their impact.
  • Lead strategic projects to improve pricing tools, processes, automation, and digital workflows.
  • Coach Pricing Operations Partners to ensure high-quality analyses and submissions.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs